EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: person:"Willan, Andrew"
Narrow search

Narrow search

Year of publication
Subject
All
Cost-effectiveness 6 Pharmacoeconomics 3 Theorie 3 Theory 3 Clinical-trial-design 2 Cost effectiveness 2 Decision-making 2 Experiment 2 Information value 2 Informationswert 2 Modelling 2 Sensitivity-analysis 2 Adolescents 1 Amoxicillin 1 Arzneimittel 1 Asthma 1 Asymmetric information 1 Asymmetrische Information 1 Bayesian-analysis 1 Children 1 Clarithromycin 1 Cost-effectiveness analysis 1 Cost-utility 1 Decision 1 Dementia 1 Duodenal ulcer 1 Entscheidung 1 Gastrokinetics 1 Geographical-locations 1 H2-antagonists 1 Healthcare-expenditure 1 Helicobacter pylori eradication therapies 1 Kosten-Wirksamkeits-Analyse 1 Lansoprazole 1 Mathematical programming 1 Mathematische Optimierung 1 Metronidazole 1 Net-monetary-benefit 1 Parkinson's-disease 1 Pharmaceuticals 1
more ... less ...
Online availability
All
Undetermined 28
Type of publication
All
Article 36 Book / Working Paper 2
Type of publication (narrower categories)
All
Article in journal 4 Aufsatz in Zeitschrift 4 Aufsatz im Buch 1 Book section 1
Language
All
Undetermined 31 English 7
Author
All
Willan, Andrew R. 25 Eckermann, Simon 15 Willan, Andrew 12 O'Brien, Bernie J. 5 Goeree, Ron 4 Blackhouse, Gordon 3 Briggs, Andrew H. 3 Akehurst, Ron 2 Boydell, Katherine 2 Brennan, Alan 2 Briggs, Andrew 2 Claxton, Karl 2 Dell, Sharon 2 Fenwick, Elisabeth 2 Fryback, Dennis 2 Hoch, Jeffrey S. 2 Marshall, Deborah 2 McCabe, Christopher 2 O'Hagan, Anthony 2 Sculpher, Mark 2 Spiegelhalter, David 2 Ades, A. E. 1 Agro, Karen 1 Armstrong, Paul W. 1 Beyene, Joseph 1 Briggs, Andrew Harvey 1 Coory, Michael 1 Faulkner, A. 1 Feldman, Brian 1 Feldman, Brian M. 1 Gertsen, Kirsten 1 Hossain, Ahmed 1 Hu, Pingzhao 1 Huang, Jia-Qing 1 Hunt, Richard 1 Hunt, Richard H. 1 Karnon, Jon 1 Kaul, Padma 1 Kowgier, Matthew E. 1 Lynd, Larry 1
more ... less ...
Published in...
All
PharmacoEconomics 17 Health Economics 12 Health economics 4 Computational Statistics & Data Analysis 1 Economic evaluation in child health 1 Statistics in practice 1 The International Journal of Biostatistics 1
more ... less ...
Source
All
RePEc 31 ECONIS (ZBW) 6 USB Cologne (EcoSocSci) 1
Showing 1 - 10 of 38
Cover Image
Statistical analysis of cost-effectiveness data
Willan, Andrew; Briggs, Andrew Harvey - 2006
Persistent link: https://www.econbiz.de/10002701620
Saved in:
Cover Image
Marginal Models for Censored Longitudinal Cost Data: Appropriate Working Variance Matrices in Inverse-Probability-Weighted GEEs Can Improve Precision
M, Pullenayegum Eleanor; R, Willan Andrew - In: The International Journal of Biostatistics 7 (2011) 1, pp. 1-27
When cost data are collected in a clinical study, interest centers on the between-treatment difference in mean cost. When censoring is present, the resulting loss of information can be limited by collecting cost data for several pre-specified time intervals, leading to censored longitudinal cost...
Persistent link: https://www.econbiz.de/10008831559
Saved in:
Cover Image
Statistical analysis of cost effectiveness data
Willan, Andrew; Briggs, Andrew H. - 2006
Persistent link: https://www.econbiz.de/10004829270
Saved in:
Cover Image
Optimal Global Value of Information Trials: Better Aligning Manufacturer and Decision Maker Interests and Enabling Feasible Risk Sharing
Eckermann, Simon; Willan, Andrew - In: PharmacoEconomics 31 (2013) 5, pp. 393-401
Risk sharing arrangements relate to adjusting payments for new health technologies given evidence of their performance over time. Such arrangements rely on prospective information regarding the incremental net benefit of the new technology, and its use in practice. However, once the new...
Persistent link: https://www.econbiz.de/10010848945
Saved in:
Cover Image
A Parent-Child Dyad Approach to the Assessment of Health Status and Health-Related Quality of Life in Children with Asthma
Ungar, Wendy J.; Boydell, Katherine; Dell, Sharon; … - In: PharmacoEconomics 30 (2012) 8, pp. 697-712
Background:Background: Assessment of health state and health-related quality of life (HR-QOL) are limited by a child's age and cognitive ability. Parent-proxy reports are known to differ from children's reports. Simultaneous assessment using a parent-child dyad is an alternative approach....
Persistent link: https://www.econbiz.de/10010556694
Saved in:
Cover Image
Value of Information and Pricing New Healthcare Interventions
Willan, Andrew R.; Eckermann, Simon - In: PharmacoEconomics 30 (2012) 6, pp. 447-459
Previous application of value-of-information methods to optimal clinical trial design have predominantly taken a societal decision-making perspective, implicitly assuming that healthcare costs are covered through public expenditure and trial research is funded by government or donation-based...
Persistent link: https://www.econbiz.de/10010548289
Saved in:
Cover Image
A Parent-Child Dyad Approach to the Assessment of Health Status and Health-Related Quality of Life in Children with Asthma
Ungar, Wendy; Boydell, Katherine; Dell, Sharon; … - In: PharmacoEconomics 30 (2012) 8, pp. 697-712
The parent-child dyad approach demonstrated moderate to strong performance characteristics in generic and disease-specific questionnaires suggesting it may be a valuable alternative to relying on parent proxies for assessing children’s utility and HR-QOL. Future research in additional...
Persistent link: https://www.econbiz.de/10011001766
Saved in:
Cover Image
ACCOUNTING FOR BETWEEN‐STUDY VARIATION IN INCREMENTAL NET BENEFIT IN VALUE OF INFORMATION METHODOLOGY
Willan, Andrew R.; Eckermann, Simon - In: Health Economics 21 (2012) 10, pp. 1183-1195
Persistent link: https://www.econbiz.de/10011005372
Saved in:
Cover Image
Value of Information and Pricing New Healthcare Interventions
Willan, Andrew; Eckermann, Simon - In: PharmacoEconomics 30 (2012) 6, pp. 447-459
Previous application of value-of-information methods to optimal clinical trial design have predominantly taken a societal decision-making perspective, implicitly assuming that healthcare costs are covered through public expenditure and trial research is funded by government or donation-based...
Persistent link: https://www.econbiz.de/10010849002
Saved in:
Cover Image
Research decisions in the face of heterogeneity : what can a new study trell us? : comment
Welton, Nicky J.; Ades, A. E. - In: Health economics 21 (2012) 10, pp. 1196-1200
Persistent link: https://www.econbiz.de/10009670413
Saved in:
  • 1
  • 2
  • 3
  • 4
  • Next
  • Last
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...